---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Recombinant Interferon Alfa-2b - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-interferon-alfa-2b
version: v1
---

# Recombinant Interferon Alfa-2b - NCI

# Recombinant Interferon Alfa-2b

Placeholder slot

(ree-KOM-bih-nunt in-ter-FEER-on AL-fuh â€¦
)

This page contains brief information about recombinant interferon alfa-2b
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Intron A

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30789790-8317-49f9-b97b-8c5ba17b53d2&audience=consumer)

## Use in Cancer

Recombinant interferon alfa-2b
is approved
to treat:

- **[AIDS-related](/Common/PopUps/popDefinition.aspx?id=444964&version=Patient&language=English) [Kaposi sarcoma](/Common/PopUps/popDefinition.aspx?id=45134&version=Patient&language=English).** It is used in certain adults who do not have many symptoms of the disease.
- **[Follicular lymphoma](/Common/PopUps/popDefinition.aspx?id=428287&version=Patient&language=English)** that is [aggressive](/Common/PopUps/popDefinition.aspx?id=45588&version=Patient&language=English). It is used with [combination chemotherapy](/Common/PopUps/popDefinition.aspx?id=45650&version=Patient&language=English) in adults.
- **[Genital warts](/Common/PopUps/popDefinition.aspx?id=409765&version=Patient&language=English)** in adults.
- **[Hairy cell leukemia](/Common/PopUps/popDefinition.aspx?id=45159&version=Patient&language=English)** in adults.
- **[Melanoma](/Common/PopUps/popDefinition.aspx?id=45135&version=Patient&language=English).** It is used as [adjuvant therapy](/Common/PopUps/popDefinition.aspx?id=45587&version=Patient&language=English) in adults who have had [surgery](/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=English) and have a high risk of [recurrent cancer](/Common/PopUps/popDefinition.aspx?id=45862&version=Patient&language=English).

Recombinant interferon alfa-2b
is also being studied in the treatment of other types of
[cancer](/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=English) and other conditions.

## More About Recombinant Interferon Alfa-2b

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/462279) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Recombinant Interferon Alfa-2b](https://medlineplus.gov/druginfo/meds/a690006.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Immune System Modulators](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immune-system-modulators)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Recombinant Interferon Alfa-2b](https://www.cancer.gov/research/participate/clinical-trials/intervention/C1953) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
